mounjaro vs retatrutide retatrutide? Comparing Effectiveness, Safety and Cost Part 2 — continuing from

Use E11.31 when the provider documents diabetic retinopathy but does not specify: Type Laterality (right, left, bilateral) Whether macular edema is present Examples of documentation that map to E11.31: Diabetic retinopathy Retinopathy due to diabetes Changes consistent with diabetic eye disease If the provider mentions macular edema or specifies the severity (mild, moderate, severe), a more specific code from the E11.32E11.39 range is required

8 However, there is no evidence supporting screening for thyroid nodules before initiating or during treatment with GLP-1 RA, nor for the inclusion of GLP-1 RA as a risk factor for thyroid cancer

SLC7A11: Solute carrier family 7 member 11

Matrix synthesis exceeds matrix degradation, and the presence of MMP inhibitors (TIMPs) controls MMP activity